They observed that a higher expression of RECQL mRNA was correlated with shorter relapse-free survival (RFS) (HR: 1.28, p-value <0.001, n= 3955) and post-progression survival (PPS) (HR: 1.32, p-value: 0.027, n= 414) in all breast cancers. Here, RECQL is linked to breast cancer.